The effect of Helicobacter pylori on insulin resistance

Digestive Diseases and Sciences

Volumn 50, Issue 11, 2005, Pages 2090-2093

  Aydemir, Selim ^a,b   Bayraktaroglu, Taner ^a   Sert, Mehmet ^a   Sokmen, Coskun ^a   Atmaca, Hulusi ^a   Mungan, Gorkem ^a   Gun, Banu Dogan ^a   Borazan, Ali ^a   Ustundag, Yucel ^a  

^a ZONGULDAK KARAELMAS UNIVERSITY   (Turkey)

^b Zonguldak Karaelmas Universitesi Tip Fakultesi   (Turkey)

Author keywords

Helicobacter pylori; Insulin resistance

Indexed keywords

ADULT; ARTICLE; ATHEROSCLEROSIS; BACTERIAL INFECTION; CHRONIC INFLAMMATION; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; GASTRITIS; HELICOBACTER PYLORI; HOMEOSTASIS; HUMAN; INSULIN RESISTANCE; ISCHEMIC HEART DISEASE; MALE; NONHUMAN; PEPTIC ULCER; PRIORITY JOURNAL;

ADULT; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; INSULIN RESISTANCE; MALE; MIDDLE AGED;

EID: 27144440828     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-005-3012-z     Document Type: Article

References (36)

1. Cave DR: Transmission and epidemiology of Helicobacter pylori. Am J Med 100:12-17, 1996
2. Pellicano R, Fagoonee S, Rizzetto M, Ponzetto A: Helicobacter pylori and coronary heart disease: which directions for future studies? Crit Rev Microbiol 29:351-359, 2003
3. Wyle FA: Helicobacter pylori: current perspectives. J Clin Gastroenterol 13(Suppl 1):S114-S124, 1991
4. Misiewicz JJ: Current insights in the pathogenesis of Helicobacter pylori infection. Eur J Gastroenterol Hepatol 7:701-703, 1995
5. Brown LM: Helicobacter pylori: epidemiology and routes of transmission. Epidemiol Rev 22:283-297, 2000
6. Leontiadis GI, Sharma VK, Howden CW: Non-gastrointestinal tract associations of Helicobacter pylori infection. Arch Intern Med 159:925-940, 1999
7. Moller DE, Flier JS: Insulin resistance - Mechanisms, syndromes, and implications. N Engl J Med 325:938-948, 1991
8. Matthaei S, Stumvoll M, Kellerer M, Haring HU: Pathophysiology and pharmacological treatment of insulin resistance. Endocr Rev 21:585-618, 2000
9. Yip J, Facchini FS, Reaven GM: Resistance to insulin-mediated glucose disposal as a predictor of cardiovascular disease. J Clin Endocrinol Metab 83:2773-2776, 1998
10. Hanley AJ, Williams K, Gonzalez C, D'Agostino RB Jr, Wagenknecht LE, Stern MP, Haffner SM: Prediction of type 2 diabetes using simple measures of insulin resistance: combined results from the San Antonio Heart Study, the Mexico City Diabetes Study, and the Insulin Resistance Atherosclerosis Study. Diabetes 52:463-469, 2003
11. Ruige JB, Assendelft WJ, Dekker JM, Kostense PJ, Heine RJ, Bouter LM: Insulin and risk of cardiovascular disease: a meta-analysis. Circulation 97:996-1001, 1998
12. Haffner SM, Miettinen H: Insulin resistance implications for type II diabetes mellitus and coronary heart disease. Am J Med 103:152-162, 1997
13. Shinohara K, Shoji T, Emoto M, Tahara H, Koyama H, Ishimura E, Miki T, Tabata T, Nishizawa Y: Insulin resistance as an independent predictor of cardiovascular mortality in patients with end-stage renal disease. J Am Soc Nephrol 13:1894-1900, 2002
14. Acbay O, Celik AF, Gundogdu S: Does Helicobacter pylori-induced gastritis enhance food-stimulated insulin release? Dig Dis Sci 41:1327-1331, 1996
15. Moss SF, Legon S, Bishop AE, Polak JM, Calam J: Effect of Helicobacter pylori on gastric somatostatin in duodenal ulcer disease. Lancet 340:930-932, 1992
16. Wallace TM, Levy JC, Matthews DR: Use and abuse of HOMA modeling. Diabetes Care 27:1487-1495, 2004
17. Bonora E, Targher G, Alberiche M, Bonadonna RC, Saggiani F, Zenere MB, Monauni T, Muggeo M: Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care 23:57-63, 2000
18. Lebovitz HE, Banerji MA: Insulin resistance and its treatment by thiazolidinediones. Recent Prog Horm Res 56:265-294, 2001
19. Lebovitz HE: Insulin resistance and the insulin resistance syndrome. In Clinician's Manual on Insulin Resistance. London, Science Press, 2002
20. Weyer C, Tataranni PA, Bogardus C, Pratley RE: Insulin resistance and insulin secretory dysfunction are independent predictors of worsening of glucose tolerance during each stage of type 2 diabetes development. Diabetes Care 24:89-94, 2001
21. Fernandez-Real JM, Ricart W: Insulin resistance and chronic cardiovascular inflammatory syndrome. Endocr Rev 24:278-301, 2003
22. Howard G, O'Leary DH, Zaccaro D, Haffner S, Rewers M, Hamman R, Selby JV, Saad MF, Savage P, Bergman R: Insulin sensitivity and atherosclerosis. The Insulin Resistance Atherosclerosis Study (IRAS) Investigators. Circulation 93:1809-1817, 1996
23. Svenson KL, Pollare T, Lithell H, Hallgren R: Impaired glucose handling in active rheumatoid arthritis: relationship to peripheral insulin resistance. Metabolism 37:125-130, 1988
24. Festa A, D'Agostino R, Jr., Howard G, Mykkanen L, Tracy RP, Haffner SM: Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS). Circulation 102:42-47, 2000
25. Candelli M, Rigante D, Marietti G, Nista EC, Crea F, Bartolozzi F, Schiavino A, Pignataro G, Silveri NG, Gasbarrini G, Gasbarrini A: Helicobacter pylori, gastrointestinal symptoms, and metabolic control in young type 1 diabetes mellitus patients. Pediatrics 111:800-803, 2003
26. Bayraktaroglu T, Aras AS, Aydemir S, Davutoglu C, Ustundag Y, Atmaca H, Borazan A: Serum levels of tumor necrosis factor-alpha, interleukin-6 and interleukin-8 are not increased in dyspeptic patients with Helicobacter pylori-associated gastritis. Mediators Inflamm 13:25-28, 2004
27. Kaneko H, Konagaya T, Kusugami K: Helicobacter pylori and gut hormones. J Gastroenterol 37:77-86, 2002
28. Calam J: Helicobacter pylori modulation of gastric acid. Yale J Biol Med 72:195-202, 1999
29. Peach HG, Barnett NE: Helicobacter pylori infection and fasting plasma glucose concentration. J Clin Pathol 54:466-469, 2001
30. Rehfeld JF, Stadil F: The effect of gastrin on basal- and glucose-stimulated insulin secretion in man. J Clin Invest 52:1415-1426, 1973
31. Colturi TJ, Unger RH, Feldman M: Role of circulating somatostatin in regulation of gastric acid secretion, gastrin release, and islet cell function. Studies in healthy subjects and duodenal ulcer patients. J Clin Invest 74:417-423, 1984
32. Candelli M, Rigante D, Marietti G, Nista EC, Crea F, Schiavino A, Cammarota G, Pignataro G, Petrucci S, Gasbarrini G, Gasbarrini A: Helicobacter pylori eradication rate and glycemic control in young patients with type 1 diabetes. J Pediatr Gastroenterol Nutr 38:422-425, 2004
33. McMahon MM, Bistrian BR: Host defenses and susceptibility to infection in patients with diabetes mellitus. Infect Dis Clin North Am 9:1-9, 1995
34. Gasbarrini A, Ojetti V, Pitocco D, De Luca A, Franceschi F, Candelli M, Sanz TE, Pola P, Ghirlanda G, Gasbarrini G: Helicobacter pylori infection in patients affected by insulin-dependent diabetes mellitus. Eur J Gastroenterol Hepatol 10:469-472, 1998
35. Oldenburg B, Diepersloot RJ, Hoekstra JB: High seroprevalence of Helicobacter pylori in diabetes mellitus patients. Dig Dis Sci 41:458-161, 1996
36. de Luis DA, de la CH, Roy G, de Argila CM, Valdezate S, Canton R, Boixeda D: Helicobacter pylori infection and insulin-dependent diabetes mellitus. Diabetes Res Clin Pract 39:143-146, 1998